It has been demonstrated that inhibition of IL-17 in the early stages of SS disease can prevent further progression of SS, especially by reducing lymphocyte infiltration into the salivary gland and maintaining normal salivary volume; similarly, blocking IL-17 in the late stages of the disease can save the function of the gland by reducing lymphocyte infiltration into the salivary gland [61]. The gene discussed is IL17A; the disease is synovial sarcoma.